Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Ligand Pharmaceuticals Incorporated LGND

Set alert

Price alert · LGND

All alert types
307.02 USD -15.73 -4.87%

At close · Nov 2

305.00 -2.02 -0.66%

After hours · Nov 2, 4:00 PM ET

Bid
306.81 × 2
Ask
307.02 × 2
306.17 Day range 324.95
175.89 52-week range 326.63
YTD
+62.38%
1 year
+60.48%
Open
323.28
Prev close
322.75
Mkt cap
6.14B
Vol
265.43K
Avg vol
241.59K
EPS
2.49
P/E
123.30
Div yield
0.00%
More statistics
Low
306.17
High
324.95
Forward P/E
25.68
Beta
1.03
Short ratio
9.25
Inst. own
116.12%
Dividend
0.00
Ex-div date
Jul 1, 2010
Earnings
Feb 25, 2027
50-d avg
296.39
200-d avg
252.66
1y target
350.92

5D chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 29, 2026Earnings: 2.67; estimate 2.33; surprise 14.59%
  • Oct 30, 2026Rating: RBC Capital · Outperform → Outperform
Signals (146)
NameTimeAgo
SMA: BearishNov 2, 3:50 PM16 hours ago
SMA: BullishNov 2, 3:45 PM16 hours ago
SMA: BearishNov 2, 3:40 PM16 hours ago
MACD: Sell SignalNov 2, 3:40 PM16 hours ago
SMA: BearishNov 2, 3:30 PM16 hours ago
RSI: OverboughtNov 2, 2:55 PM17 hours ago
SMA: BullishNov 2, 2:35 PM17 hours ago
SMA: BullishNov 2, 2:10 PM17 hours ago
RSI: OversoldNov 2, 2:00 PM17 hours ago
RSI: OversoldNov 2, 1:40 PM18 hours ago
SMA: BearishNov 2, 1:15 PM18 hours ago
SMA: BullishNov 2, 1:05 PM18 hours ago
MACD: Buy SignalNov 2, 12:55 PM19 hours ago
MACD: Sell SignalNov 2, 12:50 PM19 hours ago
RSI: OversoldNov 2, 12:45 PM19 hours ago
MACD: Buy SignalNov 2, 12:25 PM19 hours ago
MACD: Sell SignalNov 2, 10:50 AM21 hours ago
SMA: BearishNov 2, 10:40 AM21 hours ago
SMA: BearishNov 2, 10:40 AM21 hours ago
MACD: Buy SignalNov 2, 10:25 AM21 hours ago

Newest 20 of 146.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 350.92 +14.3% upside
Target (low)
247.00
Target (mean)
350.92
Target (high)
406.00
Ratings (0m) 11 11 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy8
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 11
  • 1 month ago 11
  • 2 months ago 10

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

LGND analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter2.872.43 – 3.072.02+41.9%96.72M+62.1%10
Next quarter2.312.30 – 2.311.63+41.5%76.14M+47.2%2
Current year9.499.25 – 9.748.13+16.8%291.35M+8.7%10
Next year12.2110.51 – 13.469.49+28.6%381.00M+30.8%10

Upgrades and downgrades

The latest rating changes

LGND analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026RBC CapitalMaintainedOutperformOutperform
Sep 25, 2026BarclaysInitiated—Overweight
Sep 24, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 23, 2026CitigroupMaintainedBuyBuy
Aug 14, 2026Leerink PartnersInitiated—Outperform
Aug 7, 2026RBC CapitalMaintainedOutperformOutperform
Aug 6, 2026HC Wainwright & Co.MaintainedBuyBuy
Aug 3, 2026OppenheimerReiteratedOutperformOutperform
Jul 15, 2026RBC CapitalMaintainedOutperformOutperform
Jul 9, 2026B of A SecuritiesMaintainedBuyBuy
Jul 8, 2026StifelMaintainedBuyBuy
May 8, 2026RBC CapitalMaintainedOutperformOutperform
Apr 30, 2026HC Wainwright & Co.MaintainedBuyBuy
Apr 28, 2026RBC CapitalMaintainedOutperformOutperform
Apr 15, 2026CitigroupMaintainedBuyBuy
Apr 14, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 24, 2026CitigroupMaintainedBuyBuy
Mar 11, 2026B of A SecuritiesInitiated—Buy
Feb 27, 2026OppenheimerMaintainedOutperformOutperform
Feb 24, 2026HC Wainwright & Co.MaintainedBuyBuy
Dec 10, 2025RBC CapitalMaintainedOutperformOutperform
Dec 10, 2025StifelMaintainedBuyBuy
Dec 9, 2025CitigroupInitiated—Buy
Nov 10, 2025RBC CapitalMaintainedOutperformOutperform
Nov 7, 2025BenchmarkMaintainedBuyBuy
Nov 7, 2025OppenheimerMaintainedOutperformOutperform
Nov 6, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 3, 2025OppenheimerMaintainedOutperformOutperform
Sep 3, 2025OppenheimerMaintainedOutperformOutperform
Sep 2, 2025BenchmarkMaintainedBuyBuy